Oral Session 3-15A Multiple Myeloma: Clinical (MRD/Infection)

[OS3-15A-1] Feasibility study of clinical sequencing in multiple myeloma

Masaki Ri¹, Takahiko Yasuda², Hiroshi Handa³, Tadao Ishida⁴, Hirohiko Shibayama⁵, Masahiro Abe⁶, Takashi Kanamori^1,2, Masashi Sanada², Hiroyoshi Hattori², Dai Nishijima², Hiroki Kurahashi⁷, Yuichi Shiraishi⁸, Matsuo Yamamoto², Akiko Saito², Satoru Miyano⁹, Seishi Ogawa¹⁰, Keizo Horibe², Shinsuke Iida¹ (1.Department of Hematology and Oncology, Nagoya City University, Nagoya, Japan, 2.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 3.Department of Hematology, Gunma University, Maebashi, Japan, 4.Department of Hematology, Japanese Red Cross Medical Center, 5.Department of Hematology and Oncology, Osaka University, Osaka, Japan, 6.Department of Hematology, Endocrinology and Metabolism, Tokushima University, Tokushima, Japan, 7.Department of Molecular Genetics, Fujita Health University, Toyoake, Japan, 8.Cancer Genomics and Advanced Therapeutics, National Cancer Center, Tokyo, Japan, 9.Human Genome Center, University of Tokyo, Tokyo, Japan, 10.Pathology and Tumor Biology, Kyoto University, Kyoto, Japan)